Thetis Pharmaceuticals LLC
United States of America
Aaron joined Thetis from the life science strategy consulting practice at Monitor Deloitte (former Monitor Group). While at Deloitte, he worked with Fortune 500 pharmaceutical and personal care companies across a broad range of issues, including customer strategy, analytics, and pricing, M&A, and corporate finance. He graduated Summa Cum Laude from Amherst College with a BA in Economics and Political Science.
Novel small molecule drugs to treat inflammatory bowel disease (IBD) based on a unique paradigm of resolving inflammation